Adcock Ingram Holdings Ltd (AIPJ.J)

AIPJ.J

About

Adcock Ingram Holdings Limited (Adcock Ingram) is a healthcare company, operates in a pharmaceutical division, selling prescription and over the counter products, and a hospital products and services division. The Company has three segments: Over the Counter, which consists of pharmaceutical products available without prescripti... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.41
Market Cap (Mil.):	R11,245.10
Shares Outstanding (Mil.):	175.16
Dividend:	86.00
Yield (%):	3.09

Financials

	AIPJ.J	Industry	Sector
P/E (TTM):	15.78	18.16	37.16
EPS (TTM):	4.07	--	--
ROI:	19.27	9.92	64.31
ROE:	20.32	11.17	70.34

Latest News about AIPJ.J

BRIEF-Adcock Ingram says Cosme Farma deal at 745 mln rand

JOHANNESBURG, Jan 18 - Adcock Ingram Holdings Ltd : * Says acquisition of certain assets of cosme farma laboratories limited

18 Jan 2013

» More AIPJ.J News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Adcock Ingram Holdings Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Wright Investors Service Comprehensive Report for Adcock Ingram Holdings Limited Provider: Wright Reports	$449.00 Buy
Adcock Ingram Holdings Limited (AIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy
Adcock Ingram Ltd Provider: Datamonitor	$50.00 Buy
Adcock Ingram Holdings Limited (AIP) - Financial and Strategic SWOT Analysis Review Provider: GlobalData	$125.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.